189 related articles for article (PubMed ID: 17327194)
1. Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea.
Juang P; Skledar SJ; Zgheib NK; Paterson DL; Vergis EN; Shannon WD; Ansani NT; Branch RA
Am J Infect Control; 2007 Mar; 35(2):131-7. PubMed ID: 17327194
[TBL] [Abstract][Full Text] [Related]
2. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
[TBL] [Abstract][Full Text] [Related]
3. Use of intravenous immunoglobulin in severe Clostridium difficile-associated diarrhea.
Shahani L; Koirala J
Hosp Pract (1995); 2015; 43(3):154-7. PubMed ID: 26189489
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
Pépin J; Valiquette L; Gagnon S; Routhier S; Brazeau I
Am J Gastroenterol; 2007 Dec; 102(12):2781-8. PubMed ID: 17900327
[TBL] [Abstract][Full Text] [Related]
5. Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients.
Gellad ZF; Alexander BD; Liu JK; Griffith BC; Meyer AM; Johnson JL; Muir AJ
Transpl Infect Dis; 2007 Dec; 9(4):276-80. PubMed ID: 17635835
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
McPherson S; Rees CJ; Ellis R; Soo S; Panter SJ
Dis Colon Rectum; 2006 May; 49(5):640-5. PubMed ID: 16525744
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with clostridium difficile-associated disease.
Das R; Feuerstadt P; Brandt LJ
Am J Gastroenterol; 2010 Sep; 105(9):2040-9. PubMed ID: 20389295
[TBL] [Abstract][Full Text] [Related]
8. A study of Clostridium difficile-associated disease at King Chulalongkorn Memorial Hospital, Thailand.
Pupaibool J; Khantipong M; Suankratay C
J Med Assoc Thai; 2008 Jan; 91(1):37-43. PubMed ID: 18386542
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies for C. difficile associated diarrhea.
Stepan C; Surawicz CM
Acta Gastroenterol Latinoam; 2007 Sep; 37(3):183-91. PubMed ID: 17955730
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.
Bajaj JS; Ananthakrishnan AN; Hafeezullah M; Zadvornova Y; Dye A; McGinley EL; Saeian K; Heuman D; Sanyal AJ; Hoffmann RG
Am J Gastroenterol; 2010 Jan; 105(1):106-13. PubMed ID: 19844204
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO
Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018
[TBL] [Abstract][Full Text] [Related]
12. Severe pseudomembranous colitis after moxifloxacin use: a case series.
Gallagher JC; Du JK; Rose C
Ann Pharmacother; 2009 Jan; 43(1):123-8. PubMed ID: 19066322
[TBL] [Abstract][Full Text] [Related]
13. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease.
Neal MD; Alverdy JC; Hall DE; Simmons RL; Zuckerbraun BS
Ann Surg; 2011 Sep; 254(3):423-7; discussion 427-9. PubMed ID: 21865943
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis.
Byrn JC; Maun DC; Gingold DS; Baril DT; Ozao JJ; Divino CM
Arch Surg; 2008 Feb; 143(2):150-4; discussion 155. PubMed ID: 18283139
[TBL] [Abstract][Full Text] [Related]
15. Past, present, and future therapies for Clostridium difficile-associated disease.
Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin for resistant Clostridium difficile infection.
Murphy C; Vernon M; Cullen M
Age Ageing; 2006 Jan; 35(1):85-6. PubMed ID: 16303776
[TBL] [Abstract][Full Text] [Related]
17. [Recurrent Clostridium difficile enterocolitis].
Bergamin B; Hess T; Jost R; Ballmer PE; Imoberdorf R
Schweiz Med Wochenschr; 2000 Nov; 130(44):1681-4. PubMed ID: 11103440
[TBL] [Abstract][Full Text] [Related]
18. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
Kim YG; Graham DY; Jang BI
J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile-associated diarrhea and chronic renal insufficiency.
Yousuf K; Saklayen MG; Markert RJ; Barde CJ; Gopalswamy N
South Med J; 2002 Jul; 95(7):681-3. PubMed ID: 12144071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
